Dimensional Fund Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.9M | Buy |
379,988
+165,128
| +77% | +$5.17M | ﹤0.01% | 2211 |
|
2025
Q1 | $7.21M | Sell |
214,860
-45,110
| -17% | -$1.51M | ﹤0.01% | 2377 |
|
2024
Q4 | $10.2M | Sell |
259,970
-39,895
| -13% | -$1.56M | ﹤0.01% | 2299 |
|
2024
Q3 | $11.8M | Sell |
299,865
-136,595
| -31% | -$5.38M | ﹤0.01% | 2232 |
|
2024
Q2 | $17M | Buy |
436,460
+26,253
| +6% | +$1.02M | ﹤0.01% | 2039 |
|
2024
Q1 | $17.7M | Buy |
410,207
+7,539
| +2% | +$325K | ﹤0.01% | 2053 |
|
2023
Q4 | $18.5M | Sell |
402,668
-24,457
| -6% | -$1.13M | 0.01% | 2024 |
|
2023
Q3 | $14.6M | Buy |
427,125
+165,018
| +63% | +$5.64M | ﹤0.01% | 2080 |
|
2023
Q2 | $10.1M | Buy |
262,107
+196,841
| +302% | +$7.58M | ﹤0.01% | 2253 |
|
2023
Q1 | $2.34M | Sell |
65,266
-249,407
| -79% | -$8.93M | ﹤0.01% | 2710 |
|
2022
Q4 | $12.4K | Sell |
314,673
-27,358
| -8% | -$1.08K | ﹤0.01% | 2101 |
|
2022
Q3 | $12.3M | Buy |
342,031
+167,069
| +95% | +$6.03M | ﹤0.01% | 2073 |
|
2022
Q2 | $5.32M | Sell |
174,962
-118,767
| -40% | -$3.61M | ﹤0.01% | 2427 |
|
2022
Q1 | $8.98M | Buy |
293,729
+1,783
| +0.6% | +$54.5K | ﹤0.01% | 2338 |
|
2021
Q4 | $9.12M | Buy |
291,946
+140,749
| +93% | +$4.4M | ﹤0.01% | 2341 |
|
2021
Q3 | $2.31M | Buy |
151,197
+136,187
| +907% | +$2.08M | ﹤0.01% | 2814 |
|
2021
Q2 | $279K | Buy |
+15,010
| New | +$279K | ﹤0.01% | 3273 |
|
2019
Q3 | – | Sell |
-11,120
| Closed | -$110K | – | 3438 |
|
2019
Q2 | $110K | Hold |
11,120
| – | – | ﹤0.01% | 3389 |
|
2019
Q1 | $113K | Hold |
11,120
| – | – | ﹤0.01% | 3370 |
|
2018
Q4 | $70K | Hold |
11,120
| – | – | ﹤0.01% | 3379 |
|
2018
Q3 | $147K | Hold |
11,120
| – | – | ﹤0.01% | 3331 |
|
2018
Q2 | $102K | Hold |
11,120
| – | – | ﹤0.01% | 3301 |
|
2018
Q1 | $54K | Hold |
11,120
| – | – | ﹤0.01% | 3311 |
|
2017
Q4 | $31K | Buy |
+11,120
| New | +$31K | ﹤0.01% | 3313 |
|